Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
Since the launch of its first pen needle in 1985, Novo Nordisk has been committed to enhancing injection experience by putting technology in patient hands. NovoFine® Plus is the latest example of that commitment.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
Chronic Weight Management
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
Use this online medical resource to search for answers to frequently-asked questions about Novo Nordisk products or submit a question to our Medical Information team.
(Coagulation Factor IX [Recombinant], GlycoPEGylated)
Click here for Rebinyn® Prescribing Information
(Coagulation Factor VIIa [Recombinant])
Click here for NovoSeven® RT Prescribing Information
Click here for Health Care Professionals
(Antihemophilic Factor [Recombinant])
Click here for Novoeight® Prescribing Information
(Coagulation Factor XIII A-Subunit [Recombinant])
Click here for Tretten® Prescribing Information
Click here for Norditropin® Prescribing Information
(estradiol vaginal inserts)
Click here for Vagifem® Prescribing Information
© 2018 Novo Nordisk. All rights reserved. USA18BIO00195 February 2018